Literature DB >> 25355530

SHP-1-mediated inhibitory signals promote responsiveness and anti-tumour functions of natural killer cells.

Charlotte Viant1, Aurore Fenis1, Gaëtan Chicanne2, Bernard Payrastre2, Sophie Ugolini1, Eric Vivier3.   

Abstract

Natural killer (NK) cells are cytotoxic innate lymphoid cells that are involved in immune defense. NK cell reactivity is controlled in part by MHC class I recognition by inhibitory receptors, but the underlying molecular mechanisms remain undefined. Using a mouse model of conditional deletion in NK cells, we show here that the protein tyrosine phosphatase SHP-1 is essential for the inhibitory function of NK cell MHC class I receptors. In the absence of SHP-1, NK cells are hyporesponsive to tumour cells in vitro and their early Ca(2+) signals are compromised. Mice without SHP-1 in NK cells are unable to reject MHC class I-deficient transplants and to control tumours in vivo. Thus, the inhibitory activity of SHP-1 is needed for setting the threshold of NK cell reactivity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25355530     DOI: 10.1038/ncomms6108

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  57 in total

1.  A hematopoietic cell-driven mechanism involving SLAMF6 receptor, SAP adaptors and SHP-1 phosphatase regulates NK cell education.

Authors:  Ning Wu; Ming-Chao Zhong; Romain Roncagalli; Luis-Alberto Pérez-Quintero; Huaijian Guo; Zhanguang Zhang; Christelle Lenoir; Zhongjun Dong; Sylvain Latour; André Veillette
Journal:  Nat Immunol       Date:  2016-02-15       Impact factor: 25.606

Review 2.  Strategies to enhance NK cell function for the treatment of tumors and infections.

Authors:  Jacquelyn Freund-Brown; Leilani Chirino; Taku Kambayashi
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

3.  The brave new world of innate lymphoid cells.

Authors:  Gérard Eberl; James P Di Santo; Eric Vivier
Journal:  Nat Immunol       Date:  2015-01       Impact factor: 25.606

4.  Shed NKG2D ligand boosts NK cell immunity.

Authors:  Emilie Narni-Mancinelli; Eric Vivier
Journal:  Cell Res       Date:  2015-04-07       Impact factor: 25.617

Review 5.  Shp1 function in myeloid cells.

Authors:  Clare L Abram; Clifford A Lowell
Journal:  J Leukoc Biol       Date:  2017-06-12       Impact factor: 4.962

6.  MicroRNA profiling of CD3+ CD56+ cytokine-induced killer cells.

Authors:  Wenju Wang; Ruhong Li; Mingyao Meng; Chuanyu Wei; Yanhua Xie; Yayong Zhang; Lihong Jiang; Ruiyi Dong; Chunhui Wang; Yiming Zhong; Fang Yang; Weiwei Tang; Xingfang Jin; Baohua Liu; Zongliu Hou
Journal:  Sci Rep       Date:  2015-03-31       Impact factor: 4.379

7.  Selective and Potent CDK8/19 Inhibitors Enhance NK-Cell Activity and Promote Tumor Surveillance.

Authors:  Marco H Hofmann; Rajeswaran Mani; Harald Engelhardt; Maria A Impagnatiello; Sebastian Carotta; Marc Kerenyi; Seila Lorenzo-Herrero; Jark Böttcher; Dirk Scharn; Heribert Arnhof; Andreas Zoephel; Renate Schnitzer; Thomas Gerstberger; Michael P Sanderson; Girish Rajgolikar; Swagata Goswami; Sumithira Vasu; Peter Ettmayer; Segundo Gonzalez; Mark Pearson; Darryl B McConnell; Norbert Kraut; Natarajan Muthusamy; Jürgen Moll
Journal:  Mol Cancer Ther       Date:  2020-02-05       Impact factor: 6.261

Review 8.  Natural Killer Cell Education and the Response to Infection and Cancer Therapy: Stay Tuned.

Authors:  Jeanette E Boudreau; Katharine C Hsu
Journal:  Trends Immunol       Date:  2018-01-31       Impact factor: 16.687

9.  Cognate HLA absence in trans diminishes human NK cell education.

Authors:  Vanessa Landtwing; Ana Raykova; Gaetana Pezzino; Vivien Béziat; Emanuela Marcenaro; Claudine Graf; Alessandro Moretta; Riccarda Capaul; Andrea Zbinden; Guido Ferlazzo; Karl-Johan Malmberg; Obinna Chijioke; Christian Münz
Journal:  J Clin Invest       Date:  2016-08-29       Impact factor: 14.808

10.  Diacylglycerol Kinase ζ Is a Target To Enhance NK Cell Function.

Authors:  Enjun Yang; Brenal K Singh; Amanda M Schmidt Paustian; Taku Kambayashi
Journal:  J Immunol       Date:  2016-06-24       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.